We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reducing Risk in the Treatment of Attention-Deficit/Hyperactivity Disorder Among Adults With Comorbidities.
- Authors
Kverno, Karan; Ramos-Marcuse, Fatima
- Abstract
Recent widely publicized shortages in the U.S. supply of first-line medications for treatment of attention-deficit/hyperactivity disorder (ADHD) are thought to reflect increases in public awareness, help seeking, and treatment. ADHD is one of the most common neurodevelopmental disorders and is typically identified in childhood. In adulthood, ADHD symptoms are less likely to include hyperactivity, but inattention, impulsivity, and emotional dysregulation are common. Clinical evaluation of symptomatic adults who were not diagnosed as children requires corroboration of ADHD diagnostic symptoms in childhood and careful differentiation of ADHD from frequently co-occurring psychiatric and substance use disorders. Treatment of adult ADHD can result in improved functioning across multiple dimensions and comorbid disorders. Existing guidelines and consensus statements recommend an integrated approach to treating ADHD and all existing comorbid disorders, prioritizing the disorder that is creating the most difficulty for the individual. [Journal of Psychosocial Nursing and Mental Health Services, 62(1), 8–11.]
- Subjects
UNITED States; SUBSTANCE abuse prevention; TREATMENT of attention-deficit hyperactivity disorder; RISK factors of attention-deficit hyperactivity disorder; CARDIOVASCULAR diseases risk factors; IMPULSIVE personality; FUNCTIONAL status; GANGLIONIC stimulating agents; HELP-seeking behavior; DIFFERENTIAL diagnosis; RISK assessment; ATTENTION-deficit hyperactivity disorder; AFFECTIVE disorders; INTEGRATED health care delivery; COMORBIDITY; HEALTH promotion; SYMPTOMS; ADULTS
- Publication
Journal of Psychosocial Nursing & Mental Health Services, 2024, Vol 62, Issue 1, p8
- ISSN
0279-3695
- Publication type
Article
- DOI
10.3928/02793695-20231212-01